On the number of vaccines that will be available, the health minister on Sunday said that given the population size of the country, India may have to tie up with more than one vaccine manufacturer to ensure that everyone is able to access the shot.
Bharat Biotech is currently conducting Phase 2 human trials of its Covid-19 vaccine candidate after receiving approval from the Drugs Controller General of India
Kejriwal also said that the daily testing of samples for Covid-19 has been increased in the national capital to 60,000 from the earlier 20,000 a day mark.
Globally, the infection seems to be slowing — that could change if the second wave gathers momentum in Europe, and the United State sees a third wave (it probably will ) — with the number of cases growing by just 9.2% in August, compared to 64% in July. The number of cases in India in August grew 75%, compared to 183% in July.
There must also be monitoring on a real-time basis as well as a strong push towards the behavioral change of citizens. There is no room for delay, for lives are at stake.
